dc.contributorPontifícia Universidade Católica do Rio Grande do Sul (PUCRS)
dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-27T11:21:37Z
dc.date.accessioned2022-10-05T17:57:48Z
dc.date.available2014-05-27T11:21:37Z
dc.date.available2022-10-05T17:57:48Z
dc.date.created2014-05-27T11:21:37Z
dc.date.issued2005-10-01
dc.identifierArchives of Biochemistry and Biophysics, v. 442, n. 1, p. 49-58, 2005.
dc.identifier0003-9861
dc.identifierhttp://hdl.handle.net/11449/68419
dc.identifier10.1016/j.abb.2005.07.021
dc.identifier2-s2.0-24944507288
dc.identifier9424175688206545
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3917958
dc.description.abstractPurine nucleoside phosphorylase (PNP) catalyzes the reversible phosphorolysis of nucleosides and deoxynucleosides, generating ribose 1-phosphate and the purine base, which is an important step of purine catabolism pathway. The lack of such an activity in humans, owing to a genetic disorder, causes T-cell impairment, and drugs that inhibit this enzyme may have the potential of being utilized as modulators of the immunological system to treat leukemia, autoimmune diseases, and rejection in organ transplantation. Here, we describe kinetics and crystal structure of human PNP in complex with 7-methyl-6-thio-guanosine, a synthetic substrate, which is largely used in activity assays. Analysis of the structure identifies different protein conformational changes upon ligand binding, and comparison of kinetic and structural data permits an understanding of the effects of atomic substitution on key positions of the synthetic substrate and their consequences to enzyme binding and catalysis. Such knowledge may be helpful in designing new PNP inhibitors. © 2005 Elsevier Inc. All rights reserved.
dc.languageeng
dc.relationArchives of Biochemistry and Biophysics
dc.relation3.118
dc.relation1,350
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectCrystal structure
dc.subjectDrug design
dc.subjectKinetic mechanism
dc.subjectMESG
dc.subjectPurine nucleoside phosphorylase
dc.subject7 methyl 6 thioguanosine
dc.subjectguanosine derivative
dc.subjectpurine nucleoside phosphorylase
dc.subjectunclassified drug
dc.subjectcatabolism
dc.subjectcatalysis
dc.subjectcatalyst
dc.subjectcrystal structure
dc.subjectenzyme binding
dc.subjectenzyme kinetics
dc.subjectenzyme substrate
dc.subjectenzyme substrate complex
dc.subjectligand binding
dc.subjectpriority journal
dc.subjectprotein conformation
dc.subjectstructure analysis
dc.subjectCatalysis
dc.subjectCrystallography, X-Ray
dc.subjectEnzyme Inhibitors
dc.subjectGuanosine
dc.subjectHumans
dc.subjectKinetics
dc.subjectLigands
dc.subjectPhosphorylation
dc.subjectProtein Binding
dc.subjectProtein Conformation
dc.subjectPurine-Nucleoside Phosphorylase
dc.subjectPurines
dc.subjectRibosemonophosphates
dc.subjectStructure-Activity Relationship
dc.subjectSubstrate Specificity
dc.subjectThionucleosides
dc.subjectThionucleotides
dc.titleKinetics and crystal structure of human purine nucleoside phosphorylase in complex with 7-methyl-6-thio-guanosine
dc.typeArtigo


Este ítem pertenece a la siguiente institución